Jay H. Hoofnagle
#76,552
Most Influential Person Now
Jay H. Hoofnagle's AcademicInfluence.com Rankings
Jay H. Hoofnaglelaw Degrees
Law
#1159
World Rank
#1482
Historical Rank
International Law
#100
World Rank
#148
Historical Rank
Download Badge
Law
Jay H. Hoofnagle's Degrees
- PhD Jurisprudence and Social Policy University of California, Berkeley
Why Is Jay H. Hoofnagle Influential?
(Suggest an Edit or Addition)Jay H. Hoofnagle's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. (1999) (2667)
- Classification of chronic hepatitis: Diagnosis, grading and staging (1994) (2581)
- Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. (2010) (2333)
- Viral hepatitis and liver disease (1984) (1405)
- Helicobacter pylori in peptic ulcer disease. (1994) (1317)
- Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. (1989) (1214)
- Course and outcome of hepatitis C (2002) (1072)
- National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C (1997) (1042)
- Mechanism of action of interferon and ribavirin in treatment of hepatitis C (2005) (1009)
- Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report. (1986) (1002)
- Overweight, obesity, and health risk. (2000) (945)
- Pathogenesis, Natural History, Treatment, and Prevention of Hepatitis C (2000) (932)
- Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial. (2011) (875)
- Management of hepatitis B: 2000--summary of a workshop. (2001) (787)
- A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis (2004) (732)
- Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection1 (2002) (683)
- Acute liver failure: Summary of a workshop (2007) (680)
- Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. (1996) (669)
- Management of hepatitis B: Summary of a clinical research workshop (2007) (634)
- Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. (1981) (600)
- Long‐term clinical and histopathological follow‐up of chronic posttransfusion hepatitis (1991) (579)
- Fulminant hepatic failure: Summary of a workshop (1995) (571)
- Predictors of patient and graft survival following liver transplantation for hepatitis C (1998) (570)
- Hepatitis C: The clinical spectrum of disease (1997) (529)
- Peginterferon and ribavirin for chronic hepatitis C. (2006) (501)
- Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. (2006) (495)
- THE TREATMENT OF CHRONIC VIRAL HEPATITIS (1997) (484)
- Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis. (1988) (480)
- A survey of liver transplantation from living adult donors in the United States. (2003) (457)
- Type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. (1978) (444)
- Progression of fibrosis in chronic hepatitis C. (2003) (421)
- NIH conference. Hepatocellular carcinoma. (1988) (421)
- Psychiatric complications of long-term interferon alfa therapy. (1987) (409)
- Long-term remission of chronic hepatitis B after alpha-interferon therapy. (1991) (402)
- Randomized, controlled trial of recombinant human α-interferon in patients with chronic hepatitis B (1988) (401)
- Measurements of iron status in patients with chronic hepatitis. (1992) (390)
- Reactivation of chronic hepatitis B virus infection by cancer chemotherapy. (1982) (384)
- Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. (1997) (381)
- Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C. (1991) (379)
- Gallstones and laparoscopic cholecystectomy (1993) (379)
- Systematic Review: The Effect of Preventive Lamivudine on Hepatitis B Reactivation during Chemotherapy (2008) (360)
- Hepatitis C and renal disease: an update. (2003) (357)
- Long‐term therapy of chronic hepatitis B with lamivudine (2000) (355)
- Long-term follow-up of patients with chronic hepatitis B treated with interferon alfa. (1997) (347)
- A multicenter study of the outcome of biliary atresia in the United States, 1997 to 2000. (2006) (341)
- Antibody to hepatitis-B-virus core in man. (1973) (327)
- Biliary atresia: Current concepts and research directions. Summary of a symposium (1996) (317)
- Racial differences in responses to therapy with interferon in chronic hepatitis C (1999) (309)
- Cytotoxic T lymphocyte responsiveness after resolution of chronic hepatitis B virus infection. (1996) (308)
- Optimal therapy of hepatitis C (2002) (303)
- A pilot study of ribavirin therapy for chronic hepatitis C (1992) (300)
- Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. (2011) (300)
- Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes (2000) (298)
- Hepatic Histological Findings in Suspected Drug-Induced Liver Injury: Systematic Evaluation and Clinical Associations (2013) (289)
- Reactivation of hepatitis B (2009) (289)
- Standardization of nomenclature and causality assessment in drug‐induced liver injury: Summary of a clinical research workshop (2010) (288)
- From non-A, non-B hepatitis to hepatitis C virus cure. (2015) (287)
- Chronic type B hepatitis and the “healthy” Hbsag carrier state (1987) (286)
- National Institutes of Health Consensus Development Conference: Management of Hepatitis C: 2002 (2002) (286)
- Spontaneous reactivation of chronic hepatitis B virus infection. (1984) (282)
- Molecular medicine and hemochromatosis: at the crossroads. (1999) (274)
- National Institutes of Health Consensus Development Conference Statement Management of Hepatitis C: 2002 June 10-12, 2002 (2003) (274)
- Complementary and alternative medicine in chronic liver disease (2001) (270)
- 10‐year follow‐up after interferon‐α therapy for chronic hepatitis C (1998) (266)
- Natural killer cells are polarized toward cytotoxicity in chronic hepatitis C in an interferon-alfa-dependent manner. (2010) (266)
- Ribavirin as Therapy for Chronic Hepatitis C (1995) (263)
- The effects of discontinuing pioglitazone in patients with nonalcoholic steatohepatitis (2007) (259)
- Clinical trial: pilot study of metformin for the treatment of non‐alcoholic steatohepatitis (2009) (257)
- Drug-Induced Liver Injury - Types and Phenotypes. (2019) (256)
- Drug‐induced liver injury: Mechanisms and test systems (2001) (255)
- On the role of sexual behavior in the spread of hepatitis B infection. (1975) (251)
- Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. (1990) (249)
- Primary sclerosing cholangitis: Summary of a workshop (2006) (247)
- The significance of antibody to hepatitis C virus in patients with chronic hepatitis B (1991) (247)
- Increased caffeine consumption is associated with reduced hepatic fibrosis (2010) (247)
- Interferon alfa therapy for chronic hepatitis B in children: a multinational randomized controlled trial. (1998) (238)
- A controlled trial of naloxone infusions for the pruritus of chronic cholestasis. (1992) (237)
- Development of thyroid disease during therapy of chronic viral hepatitis with interferon alfa. (1992) (236)
- Side effects of alpha interferon. (1989) (231)
- Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection. (1989) (227)
- Neutropenia during combination therapy of interferon alfa and ribavirin for chronic hepatitis C (2002) (224)
- Liver injury from herbal and dietary supplements (2017) (219)
- Screening and outcomes in biliary atresia: Summary of a National Institutes of Health workshop (2007) (216)
- Interferon alfa for patients with clinically apparent cirrhosis due to chronic hepatitis B. (1993) (216)
- A serologic follow-up of the 1942 epidemic of post-vaccination hepatitis in the United States Army. (1987) (212)
- Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C. (1991) (210)
- Genotypic analysis of hepatitis C virus in American patients (1994) (209)
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune‐suppressing and anticancer drugs: Just the tip of the iceberg? (2015) (207)
- Race, insulin resistance and hepatic steatosis in chronic hepatitis C (2007) (204)
- Spectrum of statin hepatotoxicity: Experience of the drug‐induced liver injury network (2014) (201)
- Weight change and obesity after liver transplantation: incidence and risk factors. (1998) (198)
- Primary Biliary Cirrhosis: A Model Autoimmune Disease (1983) (188)
- The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: a conference sponsored by the National Digestive Diseases Advisory Board. (1995) (188)
- Therapy of hepatitis C. (1995) (184)
- Categorization of drugs implicated in causing liver injury: Critical assessment based on published case reports (2016) (184)
- Long‐term follow‐up of patients with chronic hepatitis C treated with α‐interferon (1992) (181)
- Serologic diagnosis of acute and chronic viral hepatitis. (1991) (177)
- Use of complementary and alternative medicine in patients with liver disease (2002) (175)
- Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. (1995) (175)
- Hepatitis C viral RNA in serum of patients with chronic non‐A, non‐B hepatitis: Detection by the polymerase chain reaction using multiple primer sets (1991) (172)
- Relation of the hepatitis B virus carrier state to hepatocellular carcinoma (1987) (172)
- Donor age and outcome of liver transplantation (1996) (172)
- Persistence of hepatitis B virus DNA in the liver after loss of HBsAg in chronic hepatitis B (1993) (170)
- Course and outcome of hepatitis C (2002) (168)
- Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. (1985) (168)
- National institutes of health consensus development conference: Management of hepatitis C: 2002 (2002) (168)
- Sjögren's syndrome in patients with primary biliary cirrhosis (1990) (166)
- Antibody to hepatitis B core antigen. A sensitive indicator of hepatitis B virus replication. (1975) (166)
- Vitamin E and changes in serum alanine aminotransferase levels in patients with non‐alcoholic steatohepatitis (2013) (164)
- Drug‐induced liver injury network (DILIN) (2004) (160)
- The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. (1991) (159)
- Elevations in serum alpha‐fetoprotein levels in patients with chronic hepatitis B (1989) (157)
- Biliary Atresia: Clinical and Research Challenges for the Twenty‐First Century (2018) (153)
- Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design. (2009) (153)
- Effects of antiviral therapy on the cellular immune response in acute hepatitis C (2004) (151)
- Dieting and the development of eating disorders in overweight and obese adults. (2000) (150)
- LiverTox: A website on drug‐induced liver injury (2013) (150)
- Experimental infection of chimpanzees with hepatitis A virus. (1975) (150)
- Changes in Quality of Life After Liver Transplantation Among Adults (1997) (149)
- Randomized trial of chlorambucil for primary biliary cirrhosis. (1986) (148)
- Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity (2006) (146)
- Lamivudine for chronic delta hepatitis (1999) (146)
- Age and liver transplantation: a report of the Liver Transplantation Database. (1998) (142)
- Thymosin treatment of chronic hepatitis B: A placebo‐controlled pilot trial (1991) (142)
- Viral hepatitis, type B, DNA polymerase activity and antibody to hepatitis B core antigen. (1974) (139)
- Hepatitis B virus infection in chimpanzees: titration of subtypes. (1975) (139)
- Transmission of non-A, non-B hepatitis. (1977) (137)
- Renal tubular dysfunction during long‐term adefovir or tenofovir therapy in chronic hepatitis B (2012) (136)
- Features of Autoimmune Hepatitis in Patients With Drug‐induced Liver Injury (2017) (135)
- Therapy for hepatitis C--the costs of success. (2014) (134)
- Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C. (2003) (134)
- Living donor liver transplantation: Summary of a conference at The National Institutes of Health (2002) (131)
- Hepatitis C in African Americans: summary of a workshop. (2000) (130)
- Type D (delta) hepatitis. (1989) (128)
- Interferon in viral hepatitis: Role in pathogenesis and treatment (1986) (126)
- Important elements for the diagnosis of drug-induced liver injury. (2010) (125)
- Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy. (1999) (125)
- A short course of prednisolone in chronic type B hepatitis. Report of a randomized, double-blind, placebo-controlled trial. (2020) (123)
- Hepatitis B virus infection in the acquired immunodeficiency syndrome. (1984) (116)
- 10-Year follow-up after interferon-alpha therapy for chronic hepatitis C. (1998) (116)
- Diagnostic Accuracy of Noninvasive Fibrosis Models to Detect Change in Fibrosis Stage. (2019) (114)
- Reactivation of chronic type B hepatitis presenting as acute viral hepatitis. (1985) (113)
- Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. (1987) (113)
- Geographic distribution and genetic variability of hepatitis delta virus genotype I. (1997) (113)
- Serologic markers of hepatitis B virus infection. (1986) (111)
- Randomized Controlled Trial of Adenine Arabinoside Monophosphate for Chronic Type B Hepatitis (1984) (110)
- A Framework for Management of Hepatitis C in Prisons (2006) (109)
- Recurrent and new hepatitis C virus infection after liver transplantation (1999) (109)
- Ribavirin improves early responses to peginterferon through improved interferon signaling. (2010) (108)
- Immunoglobulin M antibody to hepatitis B core antigen in patients with chronic type B hepatitis. (1985) (107)
- Mutation rate of the hepatitis C virus NS5B in patients undergoing treatment with ribavirin monotherapy. (2007) (106)
- Increased waiting time for liver transplantation results in higher mortality. (1997) (104)
- Jaundice Due to Bacterial Infection (1979) (104)
- Immunology and the liver (1991) (103)
- Acute exacerbation of liver disease during interferon alfa therapy for chronic hepatitis C. (1992) (100)
- Changes in serum adipokine levels during pioglitazone treatment for nonalcoholic steatohepatitis: relationship to histological improvement. (2006) (99)
- Hepatitis C in asymptomatic blood donors (1997) (98)
- Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C (1992) (95)
- Maintenance therapy with ribavirin in patients with chronic hepatitis C who fail to respond to combination therapy with interferon alfa and ribavirin (2003) (95)
- National institutes of health consensus development conference statement: Management of hepatitis C: 2002 — June 10–12, 2002 (2002) (93)
- Mechanisms of action of interferon and ribavirin in chronic hepatitis C: Summary of a workshop (2007) (93)
- Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. (1998) (91)
- Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. (1994) (90)
- The interferon sensitivity determining region: All hepatitis C virus isolates are not the same (1997) (89)
- Glomerulonephritis caused by chronic hepatitis B virus infection: treatment with recombinant human alpha-interferon. (1989) (88)
- Clinical and histologic features of azithromycin-induced liver injury. (2015) (88)
- Pilot study of recombinant human α-interferon for chronic type B hepatitis (1986) (88)
- Detection of hepatitis B virus DNA in serum by polymerase chain reaction (1990) (87)
- Immunoprophylaxis of viral hepatitis. (1979) (87)
- Clinical presentations and outcomes of bile duct loss caused by drugs and herbal and dietary supplements (2017) (86)
- Type B hepatitis: virology, serology and clinical course. (1981) (85)
- The interferon system in acute and chronic viral hepatitis. (1986) (85)
- Randomized, controlled trial of recombinant human alpha-interferon in patients with chronic hepatitis B. (1988) (84)
- Hepatitis A antigen particles in liver, bile, and stool of chimpanzees. (1976) (84)
- Antibodies Against Hepatitis C Virus–Like Particles and Viral Clearance in Acute and Chronic Hepatitis C (2000) (83)
- Chronic hepatitis B. (1990) (82)
- Death and liver transplantation within 2 years of onset of drug‐induced liver injury (2017) (82)
- Subtyping of hepatitis B surface antigen and antibody by radioimmunoassay. (1977) (82)
- Long‐term therapy of chronic delta hepatitis with peginterferon alfa (2014) (82)
- SERUM LEVELS OF GAMMA-AMINOBUTYRIC-ACID-LIKE ACTIVITY IN ACUTE AND CHRONIC HEPATOCELLULAR DISEASE (1983) (81)
- Hepatic abnormalities in patients with chronic granulomatous disease (2007) (81)
- Long-term outcome of hepatitis B virus-related glomerulonephritis after therapy with interferon alfa. (1995) (80)
- Chronic type B hepatitis. (1983) (78)
- Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. (1992) (77)
- Viral hepatitis, type B, in experimental animals. (1975) (75)
- Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. (2012) (75)
- The natural history of acute hepatitis C: clinical presentation, laboratory findings and treatment outcomes (2011) (75)
- Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease. (2008) (75)
- Therapy of Viral Hepatitis (1998) (74)
- Steatosis and progression of fibrosis in untreated patients with chronic hepatitis C infection (2006) (73)
- Vitamin E deficiency in adults with chronic liver disease. (1985) (72)
- Prolonged therapy of chronic hepatitis C with ribavirin (1996) (72)
- A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B. (1993) (71)
- Treatment of chronic non‐A, non‐B hepatitis with acyclovir: Pilot study (1985) (71)
- Autoimmune hepatitis: The investigational and clinical challenges (2000) (70)
- Changes in hepatitis C virus antigen in liver with antiviral therapy. (1993) (69)
- Synthesis of antibodies to hepatitis B virus by cultured lymphocytes from chronic hepatitis B surface antigen carriers. (1983) (68)
- Increase in hepatic iron stores following prolonged therapy with ribavirin in patients with chronic hepatitis C. (1994) (67)
- Liver injury from nonsteroidal anti‐inflammatory drugs in the United States (2016) (67)
- Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity (2017) (66)
- National Institutes of Health Consensus Development Conference Statement: Management of hepatitis C: 2002—June 10‐12, 2002 (2002) (66)
- Effect of interferon-alpha on immunoglobulin synthesis by human B cells. (1986) (65)
- A step forward in therapy for hepatitis C. (2009) (64)
- Training the gastroenterologist of the future: the Gastroenterology Core Curriculum. (2003) (64)
- Reactivation of hepatitis B with reappearance of hepatitis B surface antigen after chemotherapy and immunosuppression. (2009) (64)
- Posttransfusion hepatitis B (1990) (64)
- Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. (1985) (63)
- High levels of viral replication during acute hepatitis B infection predict progression to chronicity (1994) (63)
- Duloxetine hepatotoxicity: a case‐series from the drug‐induced liver injury network (2010) (62)
- Interleukin-2 induces profound reversible cholestasis: a detailed analysis in treated cancer patients. (1989) (62)
- Studies of Donors Who Transmit Posttransfusion Hepatitis (1979) (62)
- Modeling hepatic fibrosis in African American and Caucasian American patients with chronic hepatitis C virus infection (2006) (61)
- Determination of hepatitis B virus DNA in serum using the polymerase chain reaction: Clinical significance and correlation with serological and biochemical markers (1991) (61)
- Liver transplantation for alcoholic liver disease: executive statement and recommendations. Summary of a National Institutes of Health workshop held December 6-7, 1996, Bethesda, Maryland. (1997) (60)
- Changes in quality of life after liver transplantation among adults. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Liver Transplantation Database (LTD). (1997) (60)
- Therapy of chronic hepatitis b with recombinant human alpha and gamma interferon (1990) (59)
- Passive-active immunity from hepatitis B immune globulin. Reanalysis of a Veterans Administration cooperative study of needle-stick hepatitis. The Veterans Administration Cooperative Study Group. (1979) (58)
- Effects of immunosuppressive therapy with prednisolone on B and T lymphocyte function in patients with chronic type B hepatitis (1986) (58)
- Histopathologic changes associated with fialuridine hepatotoxicity. (1997) (58)
- Management of hepatitis C: current and future perspectives. (1999) (58)
- Understanding early serum hepatitis D virus and hepatitis B surface antigen kinetics during pegylated interferon‐alpha therapy via mathematical modeling (2014) (57)
- Reactivation of chronic hepatitis B virus infection. (1987) (57)
- Effect of ribavirin on viral kinetics and liver gene expression in chronic hepatitis C (2013) (57)
- Predictors of a sustained beneficial response to interferon alfa therapy in chronic hepatitis C (1995) (56)
- Abnormal clearance of immune complexes from the circulation of patients with primary sclerosing cholangitis. (1985) (56)
- Early changes in hepatitis C virus (HCV) levels in response to peginterferon and ribavirin treatment in patients with chronic HCV genotype 1 infection. (2009) (55)
- Hepatitis B Markers in United States Drug Addicts with Special Emphasis on the Delta Hepatitis Virus (1984) (55)
- Evaluation of the patient with hepatitis B (2009) (55)
- Action plan for liver disease research (2004) (55)
- Transplacental transmission of hepatitis-B virus by symptom-free chronic carrier mothers. (1974) (54)
- Treatment of chronic delta hepatitis with recombinant human alpha interferon. (1987) (54)
- Pruritus as a Presenting Symptom of Chronic Hepatitis C (1998) (54)
- S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders. (2011) (54)
- Seizures during alpha interferon therapy. (1996) (54)
- Inhibition of duck hepatitis B virus replication by 2',3'-dideoxycytidine. A potent inhibitor of reverse transcriptase. (1989) (54)
- Durability of antibody response against hepatitis B virus in healthcare workers vaccinated as adults. (2015) (53)
- Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers. Correlation with serum markers and changes associated with loss of hepatitis B e antigen after antiviral therapy. (1987) (53)
- Cellular Immune Responses to the Hepatitis B Virus Polymerase12 (2004) (52)
- Hepatocellular carcinoma: summary and recommendations. (2004) (51)
- Antiviral therapy of hepatitis C--present and future. (1993) (51)
- Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes (2017) (51)
- A human monoclonal antibody that recognizes viral polypeptides and in vitro translation products of the genome of the hepatitis D virus. (1987) (51)
- Therapy of chronic hepatitis C with α‐interferon: The answer? Or more questions? (1991) (50)
- Complications of percutaneous liver biopsy with Klatskin needles: a 36‐year single‐centre experience (2017) (49)
- Long‐term outcome of chronic hepatitis C after sustained virological response to interferon‐based therapy (2013) (49)
- Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. (1990) (48)
- Lipoprotein abnormalities in primary biliary cirrhosis (1985) (48)
- Acute type A hepatitis during chronic hepatitis B virus infection: Association of depressed hepatitis B virus replication with appearance of endogenous alpha interferon (1984) (48)
- Stability of HCV‐RNA level and its lack of correlation with disease severity in asymptomatic chronic hepatitis C virus carriers (2001) (47)
- Idiosyncratic Drug Induced Liver Injury in African–Americans Is Associated With Greater Morbidity and Mortality Compared to Caucasians (2017) (46)
- Determination of hepatitis B phenotype using biochemical and serological markers (2017) (46)
- Optimal therapy of hepatitis C (2002) (46)
- Under-reporting and Poor Adherence to Monitoring Guidelines for Severe Cases of Isoniazid Hepatotoxicity. (2015) (45)
- New therapies for chronic hepatitis B (1997) (45)
- Transmission of hepatitis B virus infection by transfusion of frozen-deglycerolized red blood cells. (1978) (44)
- Liver injury from cyclosporine A (1990) (44)
- Therapy of acute and chronic viral hepatitis. (1994) (44)
- Hepatitis E. (2012) (44)
- Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis (1994) (43)
- Reliability of causality assessment for drug, herbal and dietary supplement hepatotoxicity in the Drug‐Induced Liver Injury Network (DILIN) (2015) (43)
- Thrombocytopenia during interferon alfa therapy. (1991) (43)
- Identification and Characterization of Fenofibrate-Induced Liver Injury (2017) (43)
- Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis (2012) (43)
- Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. (1990) (43)
- Hepatitis B Core Antigen: Immunology and Electron Microscopy (1974) (43)
- Clinical and metabolic effects associated with weight changes and obeticholic acid in non‐alcoholic steatohepatitis (2018) (42)
- The prevalence of hepatitis B surface antigen in commercially prepared plasma products. (1976) (42)
- Therapy of chronic hepatitis B with a 6-month course of ribavirin. (1994) (42)
- Adenine arabinoside 5′‐monophosphate treatment of chronic type B hepatitis (1982) (42)
- Exposure to hepatitis B virus and development of the chronic HBAg carrier state in children. (1974) (41)
- Fibrosis progression in African Americans and Caucasian Americans with chronic hepatitis C. (2008) (41)
- The physical state of the negative strand of hepatitis C virus RNA in serum of patients with chronic hepatitis C. (1994) (41)
- Therapy for acute hepatitis C. (2001) (40)
- Antibody to hepatitis B surface antigen may not always indicate immunity to hepatitis B virus infection. (1983) (40)
- Clinical and serological differentiation of autoimmune and hepatitis C virus-related chronic hepatitis (1993) (40)
- Jaundice due to bacterial infection. (1979) (40)
- Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. (2011) (40)
- Immunologic effects of interferon-alpha in man: treatment with human recombinant interferon-alpha suppresses in vitro immunoglobulin production in patients with chronic type B hepatitis. (1986) (39)
- A rapid immunochromatographic assay for hepatitis B virus screening (2003) (39)
- Hepatitis B--preventable and now treatable. (2006) (39)
- Dose‐finding study of interferon alfa‐n3 in hepatitis (1997) (38)
- Discordance among transient elastography, aspartate aminotransferase to platelet ratio index, and histologic assessments of liver fibrosis in patients with chronic hepatitis C. (2013) (38)
- Identification and Characterization of Cefazolin-Induced Liver Injury. (2015) (38)
- Primary hepatocellular carcinoma and hepatitis B virus infection in korea (1983) (38)
- Chronic non-A, non-B hepatitis. (1985) (37)
- Antibody to hepatitis B surface antigen in nonprimate animal species (1983) (37)
- Liver injury is associated with mortality in sickle cell disease (2015) (36)
- Chronic viral hepatitis--benefits of current therapies. (1996) (36)
- A pilot study of 2′,3′‐dideoxyinosine for the treatment of chronic hepatitis B (1992) (35)
- Hepatic decompensation during direct-acting antiviral therapy of chronic hepatitis C. (2016) (35)
- Treatment of chronic type C hepatitis with alpha interferon. (1989) (35)
- Sequence analysis of hepatitis C virus from patients with relapse after a sustained virological response: relapse or reinfection? (2014) (34)
- Hepatic methionine adenosyltransferase deficiency in a 31-year-old man. (1987) (34)
- Noninvasive markers for staging fibrosis in chronic delta hepatitis (2017) (34)
- Morphologic Features of the Liver in Abetalipoproteinemia (1984) (34)
- Mortality follow‐up of the 1942 epidemic of hepatitis B in the U.S. Army (1993) (34)
- Toward universal vaccination against hepatitis B virus. (1989) (33)
- The role of transjugular intrahepatic portosystemic shunt for treatment of portal hypertension and its complications: A conference sponsored by the national digestive diseases advisory board (1995) (32)
- Antibody to the Hepatitis B Surface Antigen in Immune Serum Globulin (2003) (32)
- Pilot study of interferon gamma for chronic hepatitis C. (2005) (32)
- Pathogenesis of chronic liver disease in patients with chronic hepatitis B virus infection without serum HBeAg (1996) (32)
- Hepatitis virus infection in an isolated canadian inuit (Eskimo) population (1982) (31)
- Pilot study of recombinant human alpha-interferon for chronic type B hepatitis. (1986) (31)
- Peginterferon pharmacokinetics in African American and Caucasian American patients with hepatitis C virus genotype 1 infection. (2008) (31)
- Antibody against the hepatitis type B core antigen. A new tool for epidemiologic studies. (1976) (31)
- Decline in male sexual desire, function, and satisfaction during and after antiviral therapy for chronic hepatitis C. (2009) (31)
- Peroxidase‐anti‐peroxidase detection of hepatitis B surface and core antigen in liver biopsy specimens from patients with chronic type B hepatitis (1987) (30)
- Management of hepatitis C: A national survey of gastroenterologists and hepatologists (1997) (30)
- Severe and protracted cholestasis in 44 young men taking bodybuilding supplements: assessment of genetic, clinical and chemical risk factors (2019) (30)
- Erratum: Associations of chemokine system polymorphisms with clinical outcomes and treatment responses of chronic hepatitis C (Gastroenterology (2003) 124 (352-360)) (2003) (30)
- Selective immunoglobulin A deficiency associated with primary biliary cirrhosis in a family with liver disease. (1986) (30)
- New therapies for hepatitis C (2007) (30)
- Progression of Fatty Liver Disease in Children Receiving Standard of Care Lifestyle Advice. (2020) (30)
- Intestinal malabsorption of vitamin E in primary biliary cirrhosis. (1989) (29)
- Combination Therapy with Famciclovir and Interferon-α for the Treatment of Chronic Hepatitis B (1998) (29)
- Hepatic veno-occlusive disease in a patient with systemic lupus erythematosus. (1984) (29)
- Randomized Controlled Trial of a Four Month Course of Recombinant Human Alpha Interferon in Patients with Chronic Type B Hepatitis (1987) (29)
- Intrahepatic markers of hepatitis delta virus infection: a study by in situ hybridization. (1989) (28)
- Therapy of chronic delta hepatitis with interferon alfa-2b. (1990) (28)
- Pilot study of low dose oral methotrexate treatment for primary biliary cirrhosis. (1996) (28)
- Long-term follow-up of patients with chronic hepatitis C treated with alpha-interferon. (1992) (27)
- A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis. (1990) (27)
- Effect of corticosteroid therapy on levels of antibody to hepatitis B core antigen in patients with chronic type B hepatitis (1987) (27)
- HLA‐B*35:01 and Green Tea–Induced Liver Injury (2020) (26)
- Hepatitis B in children. II. Study of children born to chronic HBsAg carrier mothers. (1978) (26)
- A Controlled Trial of Naloxone Infusions for the Pruritus of Chronic Cholestasis (1992) (26)
- The role of HLA-A*33:01 in patients with cholestatic hepatitis attributed to terbinafine. (2018) (25)
- Serologic markers of hepatitis B virus infection. (1981) (25)
- Reye's syndrome-like illness in a patient receiving amiodarone. (1988) (25)
- Asparaginase-induced hepatotoxicity: rapid development of cholestasis and hepatic steatosis (2019) (25)
- Treatment of chronic type B hepatitis with multiple ten‐day courses of adenine arabinoside monophosphate (1985) (25)
- Effects of cyclophosphamide on hepatitis B virus infection and challenge in chimpanzees. (1975) (25)
- Hepatitis G Virus and Human Immunodeficiency Virus Coinfection: Response to Interferon-α Therapy (1999) (25)
- IgM Antibody to Hepatitis B Core Antigen in Korean Patients with Hepatocellular Carcinoma (1984) (24)
- Non-A, maybe-B hepatitis. (1984) (24)
- Chronic fatigue syndrome: Lack Of association with hepatitis C virus infection (1991) (24)
- Intrahepatic markers of hepatitis delta virus infection: A study by in Situ hybridization (1989) (24)
- Association Between Severe Serum Alanine Aminotransferase Flares and Hepatitis B e Antigen Seroconversion and HBV DNA Decrease in Untreated Patients With Chronic HBV Infection. (2019) (24)
- Randomised clinical trial: the benefit of combination therapy with adefovir and lamivudine for chronic hepatitis B (2012) (24)
- Diagnosis of chronic hepatitis C: comparison of immunoassays and the polymerase chain reaction. (1994) (23)
- Lack of Transmission of Type B Hepatitis by Fiberoptic Upper Endoscopy (1980) (23)
- The Significance of Autoantibody Changes Over Time in Primary Biliary Cirrhosis. (2015) (23)
- Hepatitis C : biomedical research reports (2000) (22)
- Serological tests for non-A, non-B hepatitis: controversy. (2008) (22)
- Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN) (2016) (22)
- Cell-mediated immunity to hepatitis B surface antigen in man. (1984) (22)
- Milk thistle and chronic liver disease (2005) (21)
- Biliary Atresia Research Consortium (BARC) (2004) (21)
- The interaction of rheumatoid factor with hepatitis B surface antigen-antibody complexes. (1975) (20)
- The National Commission on Digestive Diseases (2006) (20)
- Hepatitis B surface antigen (HBS Ag) subtypes and indices of clinical disease. (1975) (20)
- A revised electronic version of RUCAM for the diagnosis of DILI (2022) (20)
- Viral kinetics in hepatitis C (2003) (20)
- Hepatitis A and B virus markers in immune serum globulin (1980) (20)
- Risk of Liver Injury Associated with Green Tea Extract in SLIMQUICK® Weight Loss Products: Results from the DILIN Prospective Study (2016) (20)
- Randomized controlled trial of adenine arabinoside monophosphate for chronic type B hepatitis. (1984) (20)
- Antibody to the Hepatitis B Virus- Associated Delta-Agent in Immune Serum Globulins (1984) (19)
- Natural history of chronic type B hepatitis. (1982) (19)
- Chronic hepatitis in hemophilia. (1977) (19)
- Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease (2018) (19)
- Decrease in serum levels of markers of hepatic connective tissue turnover during and after treatment of chronic hepatitis B with interferon‐α (1994) (19)
- Hepatic inclusions during interferon therapy in chronic viral hepatitis (1986) (18)
- Transmission of hepatitis B virus infection by asymptomatic chronic HBsAg carrier mothers. (1979) (18)
- An outbreak of type B hepatitis associated with transfusion of plasma protein fraction. (1976) (18)
- Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis (1997) (17)
- The treatment of chronic viral hepatitis. (1997) (17)
- Hepatitis B virus replication within the human spleen (1990) (17)
- Antibody to Hepatitis B Core Antigen in Blood Donors with a History of Hepatitis (1981) (17)
- Drug-induced liver injury: Icelandic lessons. (2013) (17)
- The disposition of 6‐deoxyacyclovir, a xanthine oxidase‐activated prodrug of acyclovir, in the isolated perfused rat liver (1987) (16)
- Detection and quantitation of hepatitis C virus RNA in serum using the polymerase chain reaction and a colorimetric enzymatic detection system. (1994) (16)
- Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B. (1996) (16)
- Shock wave-induced pancreatic trauma. (1991) (16)
- Hepatitis A antigen isolated from liver and stool: immunologic comparison of antisera prepared in guinea pigs. (1976) (16)
- Circulating activated B cells in primary biliary cirrhosis (1985) (16)
- Antimicrobials and anti-epileptics are the leading causes of idiosyncratic drug induced liver injury in american children. (2019) (16)
- Hepatitis B-related end-stage liver disease. (1992) (16)
- Conditions associated with hepatocellular carcinoma. (1989) (16)
- Immune response in fulminant viral hepatitis, type B. (1976) (15)
- Pyoderma gangrenosum associated with primary biliary cirrhosis. (1983) (15)
- Treatment of chronic type B hepatitis. (1989) (15)
- Important Factors in Reliable Determination of Hepatitis C Virus Genotype by Use of the 5′ Untranslated Region (2013) (15)
- The changing epidemiology of hepatitis B virus infection in the Canadian north. (1985) (15)
- Precipitin system detected in sera from patients with non‐A, non‐B hepatitis (1981) (15)
- Hepatitis B virus deoxyribonucleic acid in liver of chronic carriers (1987) (15)
- Systemic Side Effects from the Intrabiliary Infusion of Monooctanoin for the Dissolution of Gallstones (1982) (14)
- Hepatitis in patients with acute nonlymphocytic leukemia. (1983) (14)
- Antiviral therapy of chronic viral hepatitis. ACG Committee on FDA-Related Matters. (1990) (14)
- Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee. (1978) (14)
- FXR Agonists as Therapy for Liver Disease (2020) (14)
- Allopurinol hepatotoxicity is associated with human leukocyte antigen Class I alleles (2021) (14)
- Prevalence of antibody to hepatitis A virus in a Canadian Inuit community. (1982) (14)
- Sustained virologic response to interferon alpha (IFN-α) in chronic hepatitis C is associated with long-term histologic improvement and lack of hepatic HCV RNA (1998) (14)
- Serologic Evidence for Hepatitis B Virus Infection in Patients with Hemophilia B (1975) (14)
- Pipetter's thumb. (1982) (14)
- Serological diagnosis of acute viral hepatitis (1985) (14)
- Statistical models for predicting a beneficial response to interferon‐α in patients with chronic hepatitis B (1998) (13)
- Challenges in therapy of chronic hepatitis B. (2003) (13)
- Humoral and cell-mediated immune responses to two hepatitis B virus antigens in guinea pigs. (1974) (13)
- Oligoclonal immunoglobulin bands in serum in association with chronic viral hepatitis. (1990) (13)
- Hepatitis B Virus and Hepatitis B Surface Antigen in Human Albumin Products (1976) (13)
- The in vitro production of antibodies to mitochondrial antigens by peripheral blood mononuclear cells from patients with primary biliary cirrhosis (1986) (13)
- NIH conference: Primary biliary cirrhosis: a model autoimmune disease. (1983) (13)
- Serum hepatitis G virus RNA in patients with chronic viral hepatitis. (1997) (13)
- A Pilot Genome‐Wide Analysis Study Identifies Loci Associated With Response to Obeticholic Acid in Patients With NASH (2019) (13)
- Phenotypes of Chronic Hepatitis B in Children from a Large North American Cohort. (2019) (12)
- Hepatitis C Virus Infection T Cells in Chronic + Virus-Specific CD8 Impaired Effector Function of Hepatitis C (2002) (12)
- 167 Herbal and Dietary Supplement Induced Hepatotoxicity in the U.S. (2012) (12)
- Clinical significance of low molecular weight (7-8S) immunoglobulin M antibody to hepatitis B core antigen in chronic hepatitis B virus infections. (1986) (12)
- Viral hepatitis during pregnancy. (1987) (12)
- Therapy of chronic hepatitis C with alpha-interferon: the answer? Or more questions? (1991) (12)
- Hepatitis G virus infection before and after liver transplantation. Liver Transplantation Database. (1997) (12)
- Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B. (1998) (12)
- Hepatitis G virus and human immunodeficiency virus coinfection: response to interferon-alpha therapy. (1999) (11)
- Long‐term lamivudine therapy in chronic hepatitis B (2016) (11)
- Immunofluorescence microscopy in experimentally induced, type B hepatitis in the chimpanzee (1978) (11)
- Therapy of chronic viral hepatitis: past, present, and future. (1989) (11)
- NIH consensus development conference: management of Hepatitis B. Introduction. (2009) (11)
- Immune effects of α-interferon in chronic liver disease (1986) (11)
- Pilot study of pioglitazone in nonalcoholic steatohepatitis (2003) (11)
- An Epidemiologic Investigation of a Case of Acute Hepatitis E (2015) (11)
- Low‐ and standard‐dose peginterferon alfa‐2a for chronic hepatitis C, genotype 2 or 3: efficacy, tolerability, viral kinetics and cytokine response (2010) (10)
- Effect of thymosin immunostimulation with and without corticosteroid immunosuppression on chimpanzee hepatitis B carriers (1987) (10)
- Specific binding of human alpha interferon to high-affinity cell-surface binding sites on peripheral blood mononuclear cells. (1989) (9)
- Transmission of viral hepatitis, type B, by plasma derivatives. (1974) (9)
- Cross-sectional seroepidemiologic study of the prevalence of cytomegalovirus and herpes simplex virus infection in a Canadian Inuit (Eskimo) community. (1986) (9)
- Lymphokines and bile secretion in the rat. (2008) (9)
- Significance of hepatitis B core antigen in the liver in patients with chronic hepatitis B and its relation to hepatitis B virus DNA (1990) (9)
- Reports from the NIH DDDN. Research support from the Division of Digestive Diseases and Nutrition. (1990) (9)
- Anticomplement receptor activity in the serum of patients with primary biliary cirrhosis. (1986) (9)
- Clinical characteristics of antiepileptic-induced liver injury in patients from the DILIN prospective study (2021) (8)
- TRANSPLACENTAL TRANSMISSION OF HEPATITIS-B VIRUS BY SYMPTOM-FREE CHRONIC CARRIER MOTHERS (1975) (8)
- Importance of Hepatitis C Virus RNA Testing in Patients with Suspected Drug-Induced Liver Injury (2019) (8)
- Effects of recombinant human leukocyte interferon treatment of endogenous interferon production in patients with chronic type-B hepatitis. (1986) (8)
- In vitro immune responses to hepatitis B surface antigens S and preS2 during acute infection by hepatitis B virus in humans. (1990) (8)
- Acute hepatitis C. (2009) (8)
- Patient‐reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross‐sectional analysis (2020) (8)
- Primary biliary cirrhosis clinical research single‐topic conference (1996) (8)
- IgM antibody responses to hepatitis B surface antigen in recipients of hepatitis B virus vaccine. (1983) (8)
- Immune effects of alpha-interferon in chronic liver disease. (1986) (7)
- Garcinia Cambogia, Either Alone or in Combination with Green Tea Causes Moderate to Severe Liver Injury. (2021) (7)
- Type B hepatitis in Iran. (1977) (7)
- Hepatitis C viral RNA in serum of patients with chronic non-A, non-B hepatitis: detection by the polymerase chain reaction using multiple primer sets. (1992) (7)
- Hepatitis E Virus Does Not Contribute to Hepatic Decompensation Among Patients With Advanced Chronic Hepatitis C. (2016) (7)
- Denying the wolf access to sheep's clothing. (2003) (7)
- Scar undone: long-term therapy of hepatitis B (2013) (6)
- Antiviral treatment of chronic type B hepatitis. (1987) (6)
- Neonatal screening for biliary atresia (2006) (6)
- Prolonged alpha interferon therapy for chronic delta hepatitis: effect on liver histopathology. (1993) (6)
- Phenytoin hepatotoxicity masked by corticosteroids. (1989) (6)
- Therapy of chronic type B hepatitis with adenine arabinoside and adenine arabinoside monophosphate. (1986) (6)
- Type A and Type B Hepatitis (1983) (6)
- Current Concepts Hepatitis E (2012) (6)
- Durable virological response and functional cure of chronic hepatitis D after long‐term peginterferon therapy (2021) (6)
- Combination therapy of hepatitis B (2000) (5)
- Antibody to hepatitis B surface antigen in nonprimate animal species. (1983) (5)
- Letter: Effectiveness of hepatitis-B immune globulin in haemodialysis patients. (1974) (5)
- Evaluation of hepatitis B antigen testing in federally licensed blood banks in the United States. (1975) (5)
- Acute Liver Injury due to Flavocoxid (Limbrel), a Medical Food for Osteoarthritis (2012) (5)
- Drug-Induced Liver Injury - Types and Phenotypes. Reply. (2019) (5)
- Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-alpha therapy. (2003) (5)
- Methotrexate therapy of primary biliary cirrhosis: promising but worrisome. (1991) (5)
- Hepatitis delta virus RNA in serum of patients with chronic delta hepatitis (1994) (5)
- Chapter 40 – LiverTox: A Website on Drug-Induced Liver Injury (2013) (5)
- Hepatitis B virus DNA detection and comparison with hepatitis B surface antigen (1990) (5)
- Introduction (2009) (5)
- Hepatitis A and B virus markers in immune serum globulin. (1980) (5)
- Management of post-transfusion hepatitis. (1988) (4)
- Task force on training in research (1996) (4)
- Alpha interferon therapy of chronic delta hepatitis: a pilot study. (1991) (4)
- Antibody to the hepatitis B virus-associated delta-agent in immune serum globulins. (1984) (4)
- II Therapy of chronic hepatitis C (2000) (4)
- Epidemiologic research and the action plan for liver disease research. (2006) (4)
- A technique for liver biopsy in Pekin ducks. (1989) (4)
- Peginterferon Alfa-2b and ribavirin for 12 versus 24 weeks in HCV infection. (2005) (4)
- The Discovery of Hepatitis C - The 2020 Nobel Prize in Physiology or Medicine. (2020) (4)
- Current concepts in viral hepatitis. (1979) (4)
- Resolution of chronic hepatitis B-associated autoimmune neutropenia with interferon-α therapy (2003) (4)
- Liver Injury Associated with Turmeric-a Growing Problem: Ten Cases from the Drug-Induced Liver Injury Network [DILIN]. (2022) (4)
- Chronic type B hepatitis: clinical course. (1983) (4)
- Molecular biology of the hepatitis B virus. Edited by A. McLachlan, 330 pp. Boca Raton: CRC Press, 1991. $179.95 (1992) (3)
- Hepatitis B virus infection in the Wiskott-Aldrich syndrome. (1976) (3)
- Reports from the NIH DDDN (1990) (3)
- Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype. (2013) (3)
- Vitamin D receptor (VDR) polymorphisms and bone mineral density (BMD) in primary biliary cirrhosis (1995) (3)
- Therapy of chronic delta hepatitis: overview. (1993) (3)
- In vitro immune responses to hepatitis B surface antigen (pre-S2 and S) following remote infection by hepatitis B virus in humans (1989) (3)
- Thymosin: An Innovative Approach to the Treatment of Chronic Hepatitis B (1992) (3)
- Hepatitis C: Down but Not Out (2017) (3)
- HIV Through the Looking Glass: Insights Derived From Hepatitis B (2015) (3)
- Delta Hepatitis and the Hepatitis Delta Virus (1989) (3)
- LP15 : Separate and combined effects of obeticholic acid and weight loss in nonalcoholic steatohepatitis (NASH) (2015) (3)
- Reports from the NIH DDDN. Human liver tissue for research. (1990) (3)
- Acute Exacerbation of Liver Interferon Alfa Therapy for Hepatitis C 1 Disease Chronic During (1992) (3)
- Peritoneo-venous shunt for intractable ascites: Complications (1978) (3)
- Research opportunities on alcohol and liver damage (2005) (3)
- DEVELOPMENT OF A MULTI-CENTER, RANDOMIZED CONTROLLED TRIAL FOR CHILDREN WITH CHRONIC HEPATITIS C (PEDS-C): 101 (2005) (3)
- After the doubling (2004) (2)
- The 2020 Nobel Prize for Medicine or Physiology for the Discovery of Hepatitis C Virus: A Triumph of Curiosity and Persistence (2021) (2)
- 9 – VIRAL HEPATITIS (1984) (2)
- Fatigue and serum carnitine levels in chronic liver disease (2011) (2)
- Variation in Gamma Counter Efficiency Used in Radioimmunoassay Testing for Hepatitis B Surface Antigen and Antibody (1978) (2)
- 4 Acute hepatitis C (2000) (2)
- Clinical features, outcomes, and HLA risk factors associated with nitrofurantoin-induced liver injury. (2022) (2)
- Primary sclerosing cholangitis (2005) (2)
- Weight Loss from Green Tea Extracts. (2016) (2)
- Interferon alfa for treatment of pediatric chronic hepatitis B: A randomized controlled multicenter trial. (1997) (2)
- The hepatitis B research network (2009) (2)
- Detection of cells producing antibody to hepatitis B surface antigen by an indirect hemolytic plaque assay. (1974) (2)
- Incidence of Hepatitis E Infection in American Patients With Suspected Drug-Induced Liver Injury Is Low and Declining: The DILIN Prospective Study (2022) (2)
- Recombinant human α-interferon: A promissory note in non-A, non-B chronic hepatitis (1987) (1)
- Clinical and Histological Features of Azithromycin-Induced Liver Injury (2015) (1)
- Michael Charles Kew: A chronicle of his career (2018) (1)
- Cellular Immune Responses to the Hepatitis B Virus Polymerase 1 , 2 (2004) (1)
- Type B hepatitis after transfusion with blood positive for antibody to hepatitis B core antigen (Anti-HBc) (1978) (1)
- Progress on the action plan for liver disease research (2006) (1)
- Competition and selection among different HCV strains (2001) (1)
- Overweight, obesity, and mortality. (2006) (1)
- Mechanism of action of metformin in nonalcoholic steatohepatitis: authors’ reply (2009) (1)
- WEIGHT CYCLING. AUTHORS' REPLY (1995) (1)
- In vitro synthesis and immunoregulation of antibody to hepatitis B surface antigen in man (1986) (1)
- Hepatitis B (2005) (1)
- Acknowledgment to reviewers 2010 (2010) (1)
- Letter: renal tubular dysfunction during nucleotide analogue therapy in chronic hepatitis B – author's reply (2012) (1)
- Longitudinal Assessment of Bile Duct Loss in Primary Biliary Cholangitis (2022) (1)
- Characterizing Drug-Induced Liver Injury With Autoimmune Features Reply (2016) (1)
- Liver disease research funding (2004) (1)
- Levamisole in chronic hepatitis: A favorable trend is not enough (1987) (1)
- Markers of Microbial Translocation Are Elevated in Hepatitis B (HBV) and Hepatitis C (HCV) Infection; A Window Into Biology and Surrogate Markers for Detecting Disease Progression (2011) (1)
- Treatment of Chronic Hepatitis C in Non-Responders (2004) (1)
- EP1206: LIVER INJURY ASSOCIATED WITH TURMERIC–A GROWING PROBLEM: NINE CASES FROM THE DRUG-INDUCED LIVER INJURY NETWORK [DILIN] (2022) (1)
- A Modern Therapy for an Ancient Disease. (2022) (0)
- Transgenic mouse models for the chronic hepatitis B surface antigen carrier state: Transfection a deux (1986) (0)
- INCREASED MORTALITY FOLLOWING ACUTE CELLULAR REJECTION IN HCV-INFECTED LIVER TRANSPLANT RECIPIENTS (1999) (0)
- 64 Effect of early antiviral therapy on the cellular immune response in acute hepatitis C (2003) (0)
- Allan G. Redeker, M.D. (1924-2021). (2021) (0)
- Corrigendum to “Temperature rise after peginterferon alfa-2a injection in patients with chronic hepatitis C is associated with virological response and is modulated by IL28B genotype” [J Hepatol 2013; 59:957–963] (2014) (0)
- Histopathology of the liver. Volumes 1 and 2:By Gerald Klatskin and Harold O. Conn. 800 pp. $250.00. Oxford University Press, Cary, North Carolina, 1993. ISBN 0-195-043936 (1994) (0)
- The effect of antiviral therapy on HCV genotype (1995) (0)
- Reply to Antonucci et al (2009) (0)
- Hepatobiliary Pathophysiology study section (2004) (0)
- Reports from the NIH DDDN. The First award. (1991) (0)
- Ribavirin for Chronic Hepatitis C (1996) (0)
- Sa1029 Retrospective Safety Analysis of Trainee-Performed Liver Biopsies at the National Institutes of Health Clinical Center - A 35-Year Experience (2015) (0)
- Dose-finding study of interferon alfa-n3 in hepatitis C. (1997) (0)
- Immunology and liver : proceedings of the 70th Falk Symposium held in Basel, Switzerland, October 18-20, 1992 (1993) (0)
- Mortality rate during interferon alfa‐ribavirin combination therapy of chronic hepatitis C (2003) (0)
- Sa1486 - Modeling Histologic and Biochemical Improvements of Disease Severity in Chronic Hepatitis B Patients Treated with Long Term Nucleoside Analogues for Up to 18 Years and the Utility of Non-Invasive Biomarkers (2018) (0)
- Reply (2003) (0)
- Prevalence ofantibody tohepatitis Avirus inaCanadian Inuit community (1982) (0)
- Tu1008 Categorization of Drugs Implicated in Causing Liver Injury: Critical Assessment of Published Cases (2015) (0)
- Type D (Delta) Hepatitis-Reply (1989) (0)
- 1149 Cellular immune responses to the hepatitis B virus polymerase decrease during longterm antiviral therapy (2003) (0)
- 507 MODELING HDV KINETICS DURING PEGYLATED INTERFERON-ALFA TREATMENT (2012) (0)
- Hepatitis B core antigen and antibody. (1975) (0)
- Round table discussion on future developments (1986) (0)
- Prevention of type B hepatitis (1979) (0)
- The impact of patient age and corticosteroids in patients with Sulfonamide hepatotoxicity. (2023) (0)
- Mo1447 - Bile Duct Damage and Cirrhosis in Primary Biliary Cholangitis: An Investigation of Non-Invasive Biomarkers (2018) (0)
- Molecular components of hepatitis B virus: By Mark Feitelson. 273 pp., $33.95. Martinus Nijhoff Publishing, Boston, Massachusetts, 1985 (1987) (0)
- Histopathology of the liver. Volumes 1 and 2 (1994) (0)
- Introducing the AASLD President: Adrian Di Bisceglie (2014) (0)
- Sa1302 Prospective Study of Withdrawal of Oral Antiviral Therapy in Chronic Hepatitis B Patients After Prolonged Virological Response (2014) (0)
- Medium term treatment of PBC with methotrexate (MTX) does not increase hepatic DNA damage (1995) (0)
- Molecular components of hepatitis B virus (1987) (0)
- False pasitive results using commercial RT-PCR for hepatitis C virus (HCV) RNA: frequency and impact on clinical management (2001) (0)
- Very Low-Calorie Diets for Obesity-Reply (1994) (0)
- Reports from the NIH DDDN. Research training in digestive diseases. (1990) (0)
- VERY LOW-CALORIE DIETS FOR OBESITY. AUTHOR'S REPLY (1994) (0)
- 848 Cystic Fibrosis Liver Disease -Development of a Novel Criteria to Identify a Second Wave of Liver Disease in Adults (2014) (0)
- Subtyping of HBsAg by means of a commercially available radioimmunoassay. (1976) (0)
- Liver disease symptoms are associated with higher risk of adverse clinical outcomes: A longitudinal study of North American adults with chronic Hepatitis B (2021) (0)
- AASLD 2005 distinguished service award to Dr. Leonard B. Seeff (2005) (0)
- Weight Cycling-Reply (1995) (0)
- Changes in Levels of HCV-RNA and Hepatitis C Viral Antigen Associated with Interferon-alpha Therapy of Chronic Hepatitis C (1994) (0)
- Virus Genotype using the 5' Untranslated Region (2013) (0)
- Acute Hepatitis B Virus Infection in North American Adults. (2022) (0)
- 966 Hepatitis B core antigen staining in HIV-HBV coinfected patients correlates with serum HBV DNA levels but not HIV RNA levels or CD4 counts (2003) (0)
- Serum biomarkers correlated with liver stiffness assessed in a multicenter study of pediatric cholestatic liver disease (2022) (0)
- Hepatitis C Viral RNA and Hepatic Cytokine Expression in Chronic Hepatitis C: Effects of Alpha Interferon Therapy (1994) (0)
- Anti-complement receptors in PBC in the clearance of complement coated cells in primary biliary cirrhosis (2006) (0)
- P1131 : Autoimmune hepatitis-like drug induced liver injury (2015) (0)
- B Virus Polymerase Cellular Immune Responses to the Hepatitis (2013) (0)
- UPDATE ON THERAPY OF HEPATITIS C (1998) (0)
- Peds‐C (2005) (0)
- ANNOUNCEMENTS (2008) (0)
- Michael Charles Kew - Frontrunner in Hepatology. (2021) (0)
- To the editor (0)
- Symposium on management of chronic viral hepatitis focus on intron a interferon alfa 2b monte carlo monaco december 8 9 1989 (1990) (0)
- DOSE-FINDING STUDY OF INTERFERON ALFA-N3 IN HEPATITIS C. AUTHOR'S REPLY (1997) (0)
- Prevention of type B hepatitis. (1979) (0)
- Two year course of ribavirin for chronic hepatitis C (1995) (0)
- Natural History , Treatment , and Prevention of Hepatitis C Moderator : (2000) (0)
- O.151 Therapy of hepatitis B. Overview (2006) (0)
- ANNOUNCEMENTS (2008) (0)
- HIGHER PRETRANSPLANT HCV RNA LEVELS ASSOCIATED WITH POOR PATIENT AND GRAFT SURVIVAL (1998) (0)
- with repeat determinations of serum aminotransferase levels followed by repeat HBV DNA testing if aminotransferase values rise. (2002) (0)
This paper list is powered by the following services:
